Related Experiment Video
Updated: Jun 20, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Differential p53-independent outcomes of p19(Arf) loss in oncogenesis
Zhenbang Chen1, Arkaitz Carracedo, Hui-Kuan Lin
1Beth Israel Deaconess Cancer Center, Departments of Medicine and Pathology, Harvard Medical School, Boston, MA 02115, USA.
Abstract:
One reported function of the tumor suppressor p19(Arf) is to stabilize p53, providing a critical checkpoint in the response to oncogenic insults. Acute loss of Pten leads to an increase in the abundance of p19(Arf), p53, and p21 proteins as part of a fail-safe senescence response. Here, we report that loss of p19(Arf) in prostate epithelium does not accelerate-but rather partially inhibits-the prostate cancer phenotype of Pten-deficient mice. Moreover, cellular senescence and a further decrease in the number of pre-neoplastic glands were observed in prostates of the Pten-p19(Arf) double-mutant mice. In both prostate epithelium and primary mouse embryo fibroblasts (MEFs), the increase in p53 protein abundance found upon loss of Pten was unaffected by the simultaneous loss of p19(Arf). However, in contrast to that in the prostate epithelium, p19(Arf) deficiency in MEFs lacking Pten abolished cell senescence and promoted hyperproliferation and transformation despite the unabated increase in p53 abundance. Consistent with the effect of p19(Arf) loss in Pten-deficient mouse prostate, we found that in human prostate cancers, loss of PTEN was not associated with loss of p14(ARF) (the human equivalent of mouse p19(Arf)). Collectively, these data reveal differential consequences of p19(Arf) inactivation in prostate cancer and MEFs upon Pten loss that are independent of the p53 pathway.
Insights
Loss of p19(Arf) partially inhibits prostate cancer in Pten-deficient mice, unlike in other cells. This suggests tissue-specific roles for p19(Arf) in tumor suppression independent of p53.
Area of Science:
- Oncology
- Molecular Biology
- Cellular Senescence
Background:
- The tumor suppressor p19(Arf) stabilizes p53, acting as a crucial checkpoint against oncogenic stress.
- Loss of Pten in prostate epithelium triggers a senescence response, increasing p19(Arf), p53, and p21 protein levels.
Purpose of the Study:
- To investigate the role of p19(Arf) in prostate cancer development following Pten loss.
- To determine if p19(Arf) deficiency affects the senescence response and tumor progression in Pten-deficient mice.
Main Methods:
- Comparative analysis of Pten-deficient mice with and without p19(Arf) in prostate epithelium.
- Assessment of cellular senescence, pre-neoplastic gland number, and protein abundance (p53, p19(Arf)) in mouse prostate and embryo fibroblasts (MEFs).
- Examination of PTEN and p14(ARF) (human homolog of p19(Arf)) expression in human prostate cancers.
Main Results:
- Loss of p19(Arf) did not accelerate, but partially inhibited, prostate cancer in Pten-deficient mice.
- Pten-p19(Arf) double-mutant mice exhibited increased cellular senescence and reduced pre-neoplastic glands.
- In MEFs, p19(Arf) deficiency abolished senescence and promoted hyperproliferation upon Pten loss, unlike in prostate epithelium.
- p53 protein levels remained elevated in both tissues upon Pten loss, irrespective of p19(Arf) status.
- Human prostate cancers with PTEN loss did not show concomitant loss of p14(ARF).
Conclusions:
- p19(Arf) inactivation has differential effects in prostate cancer versus MEFs after Pten loss, independent of the p53 pathway.
- The tumor suppressive function of p19(Arf) in prostate cancer is distinct and context-dependent.
- These findings highlight tissue-specific mechanisms in Pten-driven tumorigenesis and senescence.
Related Concept Videos
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

